Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

AH-001 could be a safer and more effective treatment for hair loss.

Male accessory sex glands in rats rarely develop tumors and respond to hormones.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Anti-androgens can help reduce the effects of male hormones on the skin.

Regenerative therapies may help treat hair loss in androgenetic alopecia.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Suppressing certain hormones might help prevent prostate cancer.

The method effectively measures drug impact on DHT levels in prostate treatments.

Topical putrescine and spermine increased DNA synthesis in hairless mouse skin.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Estrogen and androgen signals control synaptic changes in rat brains.